Suppr超能文献

SOHO最新技术进展与后续问题:淋巴结外周T细胞淋巴瘤的病理学与发病机制

SOHO State of the Art Updates and Next Questions: Pathology and Pathogenesis of Nodal Peripheral T-Cell Lymphomas.

作者信息

Qiu Lianqun, Cho Jeong Hee, Jelloul Fatima Zahra, Vega Francisco

机构信息

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; UT Health Graduate School of Biomedical Sciences, Houston, Texas.

出版信息

Clin Lymphoma Myeloma Leuk. 2022 May;22(5):287-296. doi: 10.1016/j.clml.2021.10.006. Epub 2021 Oct 15.

Abstract

Peripheral T-cell lymphomas (PTCLs) are a heterogeneous and often clinically aggressive group of neoplasms derived from mature post-thymic T-lymphocytes. These neoplasms are rare and usually diagnostically challenging. Our understanding of the pathogenesis of PTCL is increasing and this improved knowledge is leading us to better molecular characterization, more objective and accurate diagnostic criteria, more effective risk assessment, and potentially better treatments. The focus of this paper is to present a brief overview of the current pathology criteria and molecular and genetic features of nodal peripheral T-cell lymphomas focusing on distinct genetically and molecularly defined subgroups that are being recognized within each major nodal PTCL category. It is expected that the molecular stratification will improve the diagnosis and will provide novel therapeutic opportunities (biomarker-driven and targeted therapies) that might benefit and change the outcomes of patients with these neoplasms.

摘要

外周T细胞淋巴瘤(PTCL)是一组异质性的肿瘤,通常具有临床侵袭性,起源于成熟的胸腺后T淋巴细胞。这些肿瘤较为罕见,诊断通常具有挑战性。我们对PTCL发病机制的认识不断增加,这种知识的进步正引导我们实现更好的分子特征描述、更客观准确的诊断标准、更有效的风险评估以及可能更好的治疗方法。本文的重点是简要概述淋巴结外周T细胞淋巴瘤的当前病理学标准以及分子和遗传特征,重点关注在每个主要的淋巴结PTCL类别中正在被认识到的不同的基因和分子定义的亚组。预计分子分层将改善诊断,并提供可能使这些肿瘤患者受益并改变其预后的新治疗机会(生物标志物驱动和靶向治疗)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验